Characteristics and outcomes in patients with atrial fibrillation receiving direct oral anticoagulants in off-label doses

BACKGROUND: We evaluated adherence to dosing criteria for patients with atrial fibrillation (AF) taking dabigatran or rivaroxaban and the impact of off-label dosing on thromboembolic and bleeding risk. METHODS: We used data for a retrospective cohort from a large U.S. health plan for Medicare benefi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cardiovasc Disord
Main Authors: Briasoulis, Alexandros, Gao, Yubo, Inampudi, Chakradhari, Alvarez, Paulino, Asleh, Rabea, Chrischilles, Elizabeth, Leira, Enrique C., Vaughan-Sarrazin, Mary
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6998084/
https://ncbi.nlm.nih.gov/pubmed/32013886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-020-01340-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados